Clinical Trials Browser

Melanoma, Skin Neoplasms

NCT06362369 2026-04-13

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

DermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

Turcot syndrome, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms

NCT04562129 2026-04-01

IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients

Phase 2 Recruiting

29 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT07422779 2026-02-20

MAK

Phase NA Recruiting

100 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT04996823 2025-12-04

Axitinib + Ipilimumab in Advanced Melanoma

Phase 2 Recruiting

25 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT06377111 2025-07-14

A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma

Phase 1 Recruiting

12 enrolled

Dermatologic

Melanoma, Skin Neoplasms

Clinical Trials

Cryoablation+Ipilimumab+Nivolumab in Melanoma

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients

MAK

Axitinib + Ipilimumab in Advanced Melanoma

A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma